Table 2.
Medication regimens.
| Medication regimen, N (%) | Total DKA | EuDKA | hDKA |
|---|---|---|---|
| SGLT2i only | 0 (0%) | 0 (0%) | 0 (0%) |
| SGLT2i + metformin | 1 (3.45%) | 0 (0%) | 1 (6.7%) |
| SGLT2i + thiazolidinedione | 1 (3.45%) | 1 (7.1%) | 0 (0%) |
| SGLT2i + GLP1 agonist | 1 (3.45%) | 1 (7.1%) | 0 (0%) |
| SGLT2i + sulfonylurea | 1 (3.45%) | 0 (0%) | 1 (6.7%) |
| SGLT2i + 2 agents | 10 (34.5%) | 5 (35.7%) | 5 (33.3%) |
| SGLT2i + ≥3 agents | 4 (13.8%) | 3 (21.5%) | 1 (6.7%) |
| SGLT2i + insulin ± other agents | 11 (37.9%) | 4 (28.6%) | 7 (46.6%) |